China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,140 | $5,889 | $725 | $660 |
| Short-Term Investments | $350 | $20 | $0 | $0 |
| Receivables | $1,202 | $1,325 | $150 | $136 |
| Inventory | $813 | $898 | $95 | $92 |
| Other Curr. Assets | $93 | $1,348 | $1,078 | $905 |
| Total Curr. Assets | $8,599 | $8,155 | $975 | $894 |
| Property Plant & Equip (Net) | $1,219 | $1,205 | $175 | $196 |
| Goodwill | $166 | $166 | $24 | $26 |
| Intangibles | $23 | $33 | $31 | $36 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $34 | $15 | $3 | $3 |
| Other NC Assets | $0 | $0 | -$24 | -$26 |
| Total NC Assets | $1,443 | $1,419 | $208 | $236 |
| Other Assets | $0 | -$8,224 | $0 | $0 |
| Total Assets | $10,042 | $1,350 | $1,183 | $1,130 |
| Liabilities | – | – | – | – |
| Payables | $403 | $485 | $309 | $229 |
| Short-Term Debt | $338 | $301 | $7 | $8 |
| Tax Payable | $84 | $15 | $15 | $10 |
| Deferred Revenue | $0 | $0 | $22 | $13 |
| Other Curr. Liab. | $1,624 | $1,633 | $1,335 | $852 |
| Total Curr. Liab. | $2,450 | $2,434 | $239 | $172 |
| LT Debt | $8 | $0 | $1 | $7 |
| Deferred Rev, NC | $82 | $89 | $24 | $172 |
| Deferred Tax Liab, NC | $35 | $16 | $3 | $4 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $125 | $106 | $26 | $5 |
| Other Liabilities | $0 | -$2,181 | $0 | $0 |
| Cap. Leases | $17 | $1 | $7 | $15 |
| Total Liabilities | $2,575 | $358 | $266 | $177 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $88 | $12 | $13 | $14 |
| Retained Earnings | $6,726 | $6,326 | $834 | $842 |
| AOCI | $0 | -$70 | $93 | $95 |
| Other Equity | $653 | -$5,277 | -$4,888 | -$25 |
| Total Equity | $7,467 | $992 | $917 | $926 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,042 | $1,350 | $1,183 | $1,130 |
| Net Debt | -$5,794 | -$5,587 | -$718 | -$645 |